Table 1.
Demographics of patients
| Demographics | All patients (n = 86) |
|---|---|
| Age (years old), mean ± SD | 58.92 ± 10.13 |
| CA-125 (U/ml), mean ± SD | 25.88 ± 31.06 |
| FIGO stage, n (%) | |
| IA | 52 (60.47%) |
| IB | 27 (31.40%) |
| II | 7 (8.13%) |
| Histologic subtype, n (%) | |
| Endometrioid carcinoma, grade 1 | 22 (25.58%) |
| Endometrioid carcinoma, grade 2 | 51 (59.30%) |
| Endometrioid carcinoma, grade 3 | 9 (10.47%) |
| Serous adenocarcinoma | 3 (3.49%) |
| Clear cell carcinoma | 1 (1.16%) |
| MI, n (%) | |
| ≤ 1/2 | 57 (66.28%) |
| > 1/2 | 29 (33.72%) |
| MMR, n (%) | |
| MMRp | 52 (60.47%) |
| MMRd | 34 (39.53%) |
Data were described as the mean ± SD or n (%). SD indicates standard deviation, FIGO International Federation of Gynecology and Obstetrics, MI myometrial invasion, MMRd mismatch repair deficiency, MMRp mismatch repair proficiency